During NASH progression, mitochondria are compromised by excessive β-oxidation, which leads to mitochondrial dysfunction and oxidative stress triggered by several signaling pathways involving, as previously demonstrated, the activation of the NF-κB. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatohepatitis.